• Broward Health discontinues use of HeraCARE despite positive maternal-fetal outcomes
• Recent US healthcare policy changes impact Medicaid populations
• Appointment of Aspire Health Innovations and Jeff Garibaldi to accelerate US growth

HeraMED Limited, a medical data and technology company pioneering digital maternity care, has provided an update on recent developments in the United States (US) market and the company's evolving commercial strategy. Broward Health has advised HeraMED that it will discontinue its use of HeraCARE despite positive maternal-fetal outcomes. Broward Health, as a safety net hospital, had deployed HeraCARE via a state grant to support its local underserved, Medicaid population. The agreement with Broward Health had estimated revenue in 2025 of USD$100,000 and served as an important case study. Broward continued to report significant improvements to the maternal-fetal outcomes as recently as March 2025, highlighting that the decision is not related to the clinical performance or efficacy of the HeraCARE platform. Recent changes in the US healthcare policy environment have included restructuring of Medicaid population definitions and budget allocations, with the average annual cut to the Medicaid budget anticipated to be approximately $70 billion per annum, more than ten times larger than any previous annual cut made to the program. To support its strategic shift, HeraMED has appointed Aspire Health Innovation, a leading US-based healthcare commercialisation firm, to drive strategic planning and an optimised US go-to-market (GTM) strategy. The company has also appointed Jeff Garibaldi as Chief Growth Officer US, a 35-year healthcare veteran with a proven track record. In parallel, HeraMED is refining its overall strategy, which includes exploring expansion into other significant international markets where healthcare policy environments are stable and there is a growing need for maternity care solutions.

HeraMED continues to advance existing and new opportunities in the pipeline, with a focus on health systems serving all population segments in the US. The company is also exploring expansion into other international markets with stable healthcare policy environments.